For the Inventor, By the Inventor

Enter assignee name

Richmond, VA, United States of America

Whitby Research, Inc.

USPTO Granted Patents = 35

Forward Citations = 522

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

James V Peck (18 out of 46 patents)

Gevork Minaskanian (17 out of 41 patents)

Ray A Olsson (5 out of 7 patents)

4. Eric L Nelson (4 out of 29 patents)

5. Donald A McAfee (4 out of 7 patents)

6. Robert D Thompson (4 out of 4 patents)

7. Alan S Horn (4 out of 14 patents)

8. Vithal J Rajadhyaksha (3 out of 31 patents)

9. Luiz Belardinelli (2 out of 13 patents)

10. Margarita L Dubocovich (2 out of 4 patents)

11. Mark C Sleevi (1 out of 6 patents)

12. Atef A Helmy (1 out of 2 patents)

13. L Meredith Moses (1 out of 2 patents)

14. James D Belluzzi (1 out of 1 patent)

Core Competencies:

Antiproliferative Agents

Penetration Enhancers

Cardiac Vasodilators

Dopaminergics

Adenosine Derivatives

Azacycloalkanes

Schizophrenia Treatment

Vascular Treatments

Antidepressant Agents

Transdermal Delivery

Viability Determination

Parkinsonism Treatment

35 patents: Sort by Forward Citations

1. 5382596 - Substituted 2-aminotetralins (1995-01-17),

2. 5358971 - Substituted 2-aminotetralins (1994-10-25),

3. 5314908 - Compounds useful as antiproliferative agents (1994-05-24),

4. 5310731 - N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac (1994-05-10),

5. 5283343 - 2-aryl substituted N-acetyltryptamines and process of preparing such (1994-02-01),

6. 5278150 - 2-hydrazoadenosines and their utility for the treatmeat of vascular (1994-01-11),

7. 5274003 - Substituted 2-aminotetralins (1993-12-28),

8. 5270346 - Penetration enhancers for transdermal delivery of systemic agents (1993-12-14),

9. 5268385 - Method for treating schizophrenia (1993-12-07),

10. 5256661 - Substituted 2-aminotetralins and pharmaceutical use (1993-10-26),

11. 5256647 - Compositions comprising 1-substituted azacycloalkanes (1993-10-26),

12. 5256398 - Composition for determining viability of tissue (1993-10-26),

13. 5234959 - Penetration enhancers for transdermal delivery of systemic agents (1993-08-10),

14. 5234945 - Method of producing body weight and food intake using a dopamine D2 (1993-08-10),

15. 5218113 - N-substituted thiolactams (1993-06-08),

Company Overview

Whitby Research, Inc. is a technology-focused organization based in Richmond, VA, specializing in advanced research and development across various domains. The company is dedicated to innovating solutions in fields such as data analytics, artificial intelligence, and software engineering. By leveraging cutting-edge technologies, Whitby Research aims to enhance operational efficiencies and drive progress in industries that rely on sophisticated data-driven insights. Their commitment to research excellence positions them as a key player in the technology landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

35 Patents

#23 in Richmond, VA

#164 in Virginia

#9,740 in US

#19,148 in the World

Richmond, VA, United States of America

Whitby Research, Inc.

Forward Citations = 522

14 inventors:

James V Peck (18 out of 46 patents)

Gevork Minaskanian (17 out of 41 patents)

Ray A Olsson (5 out of 7 patents)

4. Eric L Nelson (4 out of 29 patents)

5. Donald A McAfee (4 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Whitby Research, Inc.. Retrieved from https://idiyas.com/company/whitby-research

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…